Delhi HC Clears Zydus’ Cancer Drug ZRC-3276 Despite BMS Patent Claim

Day 1 conference highlights include news from Moderna, BridgeBio

DRRA5 hours ago 0

FDA again rejects tabelecleucel for EBV-driven post-transplant lymphoproliferative disease

DRRA5 hours ago 0

New data, nuances in managing resistant gram-negative infections

DRRA6 hours ago 0

New Year’s resolutions 2026: Lessons from colleagues

DRRA7 hours ago 0